BDBM164267 US9669031, 6 6′-(pyrimidin-4-ylamino)-1′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′(2′H)-dione (Cpd. No. 6)

SMILES O=C1NC2(CCCC2)n2c1ccc(Nc1ccncn1)c2=O

InChI Key InChIKey=PIZDEEXJCJSPIZ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 164267   

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
Effector Therapeutics

US Patent
LigandPNGBDBM164267(US9669031, 6 6′-(pyrimidin-4-ylamino)-1̸...)
Affinity DataIC50:  55nMT: 2°CAssay Description:Compounds are screened for Mnk inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-interacting serine/threonine-protein kinase 1(Homo sapiens (Human))
Effector Therapeutics

US Patent
LigandPNGBDBM164267(US9669031, 6 6′-(pyrimidin-4-ylamino)-1̸...)
Affinity DataIC50: <10nMT: 2°CAssay Description:Compounds are screened for Mnk inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent